MedPath

A clinical study to evaluate the efficacy of ayurvedic therapeutics on Pitta Vidagdha drishti w.s.r to Dry Age related Macular Degeneratio

Phase 2
Conditions
Health Condition 1: H353- Degeneration of macula and posterior pole
Registration Number
CTRI/2020/06/026080
Lead Sponsor
ational Institute of Ayurveda
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Patients between age of 40 to 70 years.2. Willing to sign the informed consent form, follows study instructions and complete all study visits.

3. Patients presenting with classical sign and symptoms of Pitta Vidagdha Drishti & evidence of Dry ARMD (i.e, presence of drusens or pigmentary changes in macula).

Exclusion Criteria

Ophthalmic-

1. Presence of any other retinal or macular pathology other than Non-Exudative ARMD such as Exudative ARMD, Diabetic retinopathy, Central geographic atrophy, Haemorrhagic condition of fundus or retinal fluid.

2. History of retinal laser or surgical therapy in study eye.

3. Contraindication of pupil dilatation in the study eye.

4. Mature cataract or media opacification in either eye which limits an adequate view of fundus.

5. Unable to maintain stable fixation for OCT imagining.

Systemic-

Disorders other than ocular conditions such as uncontrolled hypertension, uncontrolled diabetes mallitus, severe cardiac diseases, and deranged lipid profile.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Changes in visual acuity & Number and size of drusens in the maculaTimepoint: 46 days
Secondary Outcome Measures
NameTimeMethod
Change in color vision <br/ ><br>Change in metamorphopsia (Amsler grid test findings) <br/ ><br> Changes in fundus examination <br/ ><br>Timepoint: 46 days
© Copyright 2025. All Rights Reserved by MedPath